|
US9752113B2
(en)
|
2012-03-15 |
2017-09-05 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10322949B2
(en)
|
2012-03-15 |
2019-06-18 |
Flodesign Sonics, Inc. |
Transducer and reflector configurations for an acoustophoretic device
|
|
US10689609B2
(en)
|
2012-03-15 |
2020-06-23 |
Flodesign Sonics, Inc. |
Acoustic bioreactor processes
|
|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
|
US9745548B2
(en)
|
2012-03-15 |
2017-08-29 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US10967298B2
(en)
|
2012-03-15 |
2021-04-06 |
Flodesign Sonics, Inc. |
Driver and control for variable impedence load
|
|
US9950282B2
(en)
|
2012-03-15 |
2018-04-24 |
Flodesign Sonics, Inc. |
Electronic configuration and control for acoustic standing wave generation
|
|
US10737953B2
(en)
|
2012-04-20 |
2020-08-11 |
Flodesign Sonics, Inc. |
Acoustophoretic method for use in bioreactors
|
|
EP4282419A1
(en)
|
2012-12-20 |
2023-11-29 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
US9745569B2
(en)
|
2013-09-13 |
2017-08-29 |
Flodesign Sonics, Inc. |
System for generating high concentration factors for low cell density suspensions
|
|
WO2015105955A1
(en)
|
2014-01-08 |
2015-07-16 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
US9744483B2
(en)
|
2014-07-02 |
2017-08-29 |
Flodesign Sonics, Inc. |
Large scale acoustic separation device
|
|
AU2015312117A1
(en)
|
2014-09-02 |
2017-03-02 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by Myd88 and CD40 polypeptides
|
|
CA2978171A1
(en)
*
|
2015-03-10 |
2016-09-15 |
J.H. Frederik Falkenburg |
T-cell receptors directed against the preferentially expressed antigen of melanoma and uses thereof
|
|
US11021699B2
(en)
|
2015-04-29 |
2021-06-01 |
FioDesign Sonics, Inc. |
Separation using angled acoustic waves
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
ES2970865T3
(es)
|
2015-12-16 |
2024-05-31 |
Gritstone Bio Inc |
Identificación, fabricación y uso de neoantígenos
|
|
US11325948B2
(en)
|
2016-03-19 |
2022-05-10 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL
|
|
US12590321B2
(en)
|
2016-03-19 |
2026-03-31 |
Exuma Biotech Corp. |
Methods and compositions for genetically modifying and expanding lymphocytes and regulating the activity thereof
|
|
US11111505B2
(en)
|
2016-03-19 |
2021-09-07 |
Exuma Biotech, Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
EP3439675A4
(en)
|
2016-04-08 |
2019-12-18 |
Purdue Research Foundation |
METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY
|
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
WO2018075830A1
(en)
|
2016-10-19 |
2018-04-26 |
Flodesign Sonics, Inc. |
Affinity cell extraction by acoustics
|
|
CN110191955B
(zh)
|
2016-12-13 |
2024-05-31 |
西雅图儿童医院（Dba西雅图儿童研究所） |
在体外和体内对工程化的细胞中表达的化学物质诱导的信号传导复合物进行外源性药物激活的方法
|
|
US11649288B2
(en)
|
2017-02-07 |
2023-05-16 |
Seattle Children's Hospital |
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
|
|
WO2018160622A1
(en)
|
2017-02-28 |
2018-09-07 |
Endocyte, Inc. |
Compositions and methods for car t cell therapy
|
|
EP3621988A1
(en)
|
2017-05-09 |
2020-03-18 |
Bellicum Pharmaceuticals, Inc. |
Methods to augment or alter signal transduction
|
|
WO2019032628A1
(en)
|
2017-08-07 |
2019-02-14 |
The Regents Of The University Of California |
GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
|
|
EP3735460A4
(en)
*
|
2017-09-18 |
2021-08-11 |
Exuma Biotech Corp. |
METHODS AND COMPOSITIONS FOR THE GENETIC MODIFICATION AND EXPANSION OF LYMPHOCYTES AND THE REGULATION OF THE ACTIVITY OF THE LATTER
|
|
EP4576103A3
(en)
|
2017-10-10 |
2025-08-27 |
Gritstone bio, Inc. |
Neoantigen identification using hotspots
|
|
CN111630602A
(zh)
|
2017-11-22 |
2020-09-04 |
磨石肿瘤生物技术公司 |
减少新抗原的接合表位呈递
|
|
WO2019113509A2
(en)
|
2017-12-08 |
2019-06-13 |
Bellicum Pharmaceuticals, Inc. |
Methods for enhancing and maintaining car-t cell efficacy
|
|
KR102439221B1
(ko)
|
2017-12-14 |
2022-09-01 |
프로디자인 소닉스, 인크. |
음향 트랜스듀서 구동기 및 제어기
|
|
US20200308144A1
(en)
|
2017-12-20 |
2020-10-01 |
Bellicum Pharmaceuticals, Inc. |
Multimeric piperidine derivatives
|
|
IL316257A
(en)
|
2017-12-22 |
2024-12-01 |
Fate Therapeutics Inc |
Enhanced immune effector cells and use thereof
|
|
US11311576B2
(en)
|
2018-01-22 |
2022-04-26 |
Seattle Children's Hospital |
Methods of use for CAR T cells
|
|
US12312416B2
(en)
|
2018-02-06 |
2025-05-27 |
Seattle Children's Hospital |
Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumors
|
|
AU2019225174B2
(en)
|
2018-02-23 |
2025-11-20 |
Endocyte, Inc. |
Sequencing method for CAR T cell therapy
|
|
EP3759131A4
(en)
|
2018-02-27 |
2021-12-01 |
Gritstone bio, Inc. |
NEOANTIGEN IDENTIFICATION WITH PAN ALLELE MODELS
|
|
KR102817092B1
(ko)
|
2018-03-29 |
2025-06-09 |
페이트 세러퓨틱스, 인코포레이티드 |
조작된 면역 효과기 세포 및 이의 용도
|
|
WO2019210057A1
(en)
|
2018-04-27 |
2019-10-31 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Rapamycin resistant cells
|
|
WO2019222579A1
(en)
|
2018-05-17 |
2019-11-21 |
St. Jude Children's Research Hospital, Inc. |
Chimeric antigen receptors with myd88 and cd40 costimulatory domains
|
|
CN111373571A
(zh)
|
2018-07-26 |
2020-07-03 |
株式会社Lg化学 |
隔板和包括该隔板的电化学装置
|
|
MX2021006194A
(es)
|
2018-12-02 |
2021-06-30 |
Fate Therapeutics Inc |
Inmunoterapias mediante el uso de celulas efectoras potenciadas derivadas de ipsc.
|
|
WO2020123766A1
(en)
*
|
2018-12-13 |
2020-06-18 |
Bellicum Pharmaceuticals, Inc. |
Psca car-t cells
|
|
EP3920888A4
(en)
*
|
2019-02-04 |
2023-11-01 |
Oisin Biotechnologies, Inc. |
FUSOGENIC LIPID NANOPARTICLES FOR TARGET CELL-SPECIFIC PRODUCTION OF RAPAMYCIN-INDUCIBLE THERAPEUTIC PROTEINS
|
|
US20220204575A1
(en)
*
|
2019-04-23 |
2022-06-30 |
The Regents Of The University Of California |
Modulating survival of therapeutic cells and methods, cells and nucleic acids related thereto
|
|
CN110079504A
(zh)
*
|
2019-05-06 |
2019-08-02 |
山东大学第二医院 |
一种含有不稳定结构域的car-t细胞及其制备方法和调节car-t细胞功能方法
|
|
CN114258429A
(zh)
|
2019-07-17 |
2022-03-29 |
菲特治疗公司 |
免疫效应细胞工程化和其用途
|
|
WO2021030482A1
(en)
*
|
2019-08-12 |
2021-02-18 |
Bellicum Pharmaceuticals, Inc. |
Improved formulations for immune cells
|
|
CN110592014A
(zh)
*
|
2019-08-14 |
2019-12-20 |
广东美赛尔细胞生物科技有限公司 |
一种在nk细胞治疗中免辐照体外体内持续去除饲养细胞的方法
|
|
CN112430578A
(zh)
*
|
2019-08-26 |
2021-03-02 |
深圳宾德生物技术有限公司 |
携带安全开关并靶向Her2的嵌合抗原受体T细胞及其制备方法和应用
|
|
CA3149583A1
(en)
*
|
2019-08-30 |
2021-03-04 |
Shattuck Labs, Inc. |
Chimeric proteins in autoimmunity
|
|
US20230104317A1
(en)
*
|
2020-01-31 |
2023-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Systems and Methods to Identify Genetic Silencers and Applications Thereof
|
|
CN115210252A
(zh)
|
2020-02-04 |
2022-10-18 |
西雅图儿童医院（Dba西雅图儿童研究所） |
抗二硝基苯酚的嵌合抗原受体
|
|
WO2021231806A1
(en)
*
|
2020-05-13 |
2021-11-18 |
Rapa Therapeutics, Llc |
Antigen presenting t cells, sensitized, manufactured t cells and methods of treatment using the same
|
|
WO2021257574A1
(en)
*
|
2020-06-15 |
2021-12-23 |
Kiromic Biopharma Inc. |
Tri-switch technology for multi-dimensional control of cell therapy
|
|
BR112022025806A2
(pt)
|
2020-06-19 |
2023-03-07 |
Fate Therapeutics Inc |
Combinação de tipos de células efetoras derivadas de ipsc para uso em imunoterapia
|
|
CN112575035B
(zh)
*
|
2020-12-09 |
2022-11-29 |
贵州医科大学 |
一种诱导细胞凋亡的载体系统
|
|
US20250228943A1
(en)
|
2022-04-08 |
2025-07-17 |
Fate Therapeutics, Inc. |
Cells having solid tumor targeting backbone and use thereof
|
|
US20250222029A1
(en)
|
2022-04-08 |
2025-07-10 |
Fate Therapeutics, Inc. |
Chimeric antigen receptor for tumor targeting
|
|
CN119654336A
(zh)
*
|
2022-05-16 |
2025-03-18 |
儿童医疗中心有限公司 |
治疗心脏病的组合物和方法
|
|
EP4634216A1
(en)
|
2022-12-16 |
2025-10-22 |
Repertoire Immune Medicines, Inc. |
T cell receptors binding hpv-16 epitopes
|
|
AU2024337093A1
(en)
*
|
2023-09-05 |
2026-04-02 |
Remedium Bio, Inc. |
Genetic elements for adjustment of expression
|